[ TRANSACTION RECORD ]

Johnson & Johnson Investment in Abiomed — 2022

VERIFIED VECTOR ID: 001512 · tx-040
M SOURCE NODE — FUNDER
Johnson & Johnson
Healthcare United States
$16,600,000,000
EQUITY
22/12/2022
Q DESTINATION NODE — RECIPIENT
Abiomed
Company United States
Amount (USD)
$16.6B
Flow Type
EQUITY
Transaction Date
22/12/2022
Primary Source
View Filing ↗
Funder Profile [ M ]
Entity Johnson & Johnson
AUM 190000
HQ Location United States
Sector Healthcare
Recipient Profile [ Q ]
Entity Abiomed
Entity Type Company
Jurisdiction United States
Intelligence Note

Johnson & Johnson finalized the acquisition of Abiomed for 16.6 billion dollars, expanding its MedTech division with a leader in heart recovery. The transaction provides J&J with a high-growth platform in the circulatory support market. This deal is one of the largest institutional healthcare acquisitions in the field of cardiovascular technology.

Σ
Primary Forensic Source https://www.jnj.com/media-center/press-releases/johnson-johnson-completes-acquisition-of-abiomed/
✓ SOURCE LINKED